ClinicalTrials.govpublic full text
Use of Cannabinoids in Patients With Multiple Sclerosis
multiple sclerosis, cannabinoids, spasticity, fmri, tms, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836438
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.